Renaissance Technologies LLC Acquires 799,900 Shares of Envista Holdings Corporation $NVST

Renaissance Technologies LLC lifted its holdings in Envista Holdings Corporation (NYSE:NVST) by 195.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,208,165 shares of the company’s stock after buying an additional 799,900 shares during the quarter. Renaissance Technologies LLC’s holdings in Envista were worth $30,651,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the business. Millennium Management LLC lifted its position in Envista by 1,442.7% during the 4th quarter. Millennium Management LLC now owns 2,420,615 shares of the company’s stock valued at $52,552,000 after acquiring an additional 2,263,712 shares during the period. Holocene Advisors LP purchased a new stake in Envista in the second quarter worth about $43,936,000. Arrowstreet Capital Limited Partnership grew its holdings in Envista by 341.5% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,858,293 shares of the company’s stock worth $72,515,000 after purchasing an additional 2,210,847 shares during the period. Norges Bank bought a new position in shares of Envista during the fourth quarter valued at approximately $45,113,000. Finally, Alliancebernstein L.P. increased its stake in shares of Envista by 34.0% during the second quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock valued at $119,164,000 after purchasing an additional 1,547,656 shares in the last quarter.

Envista Stock Up 1.3%

Shares of Envista stock opened at $27.00 on Wednesday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.06 and a current ratio of 2.44. The stock has a market capitalization of $4.39 billion, a PE ratio of 65.85, a price-to-earnings-growth ratio of 1.51 and a beta of 0.86. Envista Holdings Corporation has a 52-week low of $18.77 and a 52-week high of $30.42. The company has a 50-day simple moving average of $25.34 and a two-hundred day simple moving average of $25.82.

Envista (NYSE:NVST) last issued its earnings results on Wednesday, May 6th. The company reported $0.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.05. Envista had a net margin of 2.41% and a return on equity of 7.11%. The firm had revenue of $705.50 million for the quarter, compared to the consensus estimate of $680.03 million. During the same quarter in the prior year, the firm posted $0.24 earnings per share. The business’s revenue was up 14.4% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. On average, analysts anticipate that Envista Holdings Corporation will post 1.42 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on NVST shares. Citigroup started coverage on shares of Envista in a report on Wednesday, April 15th. They set a “neutral” rating and a $29.00 target price for the company. Evercore reaffirmed an “outperform” rating and set a $33.00 price objective on shares of Envista in a research report on Thursday, May 7th. Barclays lowered their price objective on Envista from $34.00 to $32.00 and set an “overweight” rating for the company in a research note on Thursday, June 11th. Robert W. Baird boosted their target price on Envista from $30.00 to $31.00 and gave the stock an “outperform” rating in a report on Thursday, May 7th. Finally, Weiss Ratings cut Envista from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 11th. Six analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $28.54.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.